O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.61%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11B
AUM Growth
+$11B
(+12%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
40.32%
Holding
136
New
6
Increased
34
Reduced
26
Closed
7
Top Buys
| 1 |
Viatris
VTRS
|
$171M |
| 2 |
Gilead Sciences
GILD
|
$125M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$96.4M |
| 4 |
Puma Biotechnology
PBYI
|
$81.8M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$73.4M |
Top Sells
| 1 |
Molina Healthcare
MOH
|
$160M |
| 2 |
SHPG
Shire pic
SHPG
|
$84.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$73.6M |
| 4 |
McKesson
MCK
|
$69.2M |
| 5 |
Illumina
ILMN
|
$52.6M |
Sector Composition
| 1 | Healthcare | 90.59% |
| 2 | Financials | 0.18% |
| 3 | Technology | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agilent Technologies
A
$35.4B
| $139M | 1.26% |
3,326,000
-213,000
| -6% | -$8.91M |
|
27
Eli Lilly
LLY
$657B
| $136M | 1.23% |
1,613,000
+341,000
| +27% | +$28.7M |
|
28
Pfizer
PFE
$141B
| $133M | 1.21% |
4,124,000
+361,000
| +10% | +$11.7M |
|
29
Intuitive Surgical
ISRG
$161B
| $131M | 1.18% |
239,000
| – | – |
|
30
Ironwood Pharmaceuticals
IRWD
$210M
| $130M | 1.18% |
11,226,400
| – | – |
|
|
INSY
31
DELISTED
Insys Therapeutics, Inc.
INSY
| $125M | 1.13% |
4,366,740
+284,940
| +7% | +$8.16M |
|
32
Cooper Companies
COO
$13.2B
| $123M | 1.11% |
914,900
-386,500
| -30% | -$51.9M |
|
|
MGLN
33
DELISTED
Magellan Health Services, Inc.
MGLN
| $113M | 1.02% |
1,833,000
| – | – |
|
|
AGN.PRA
34
DELISTED
Allergan plc.
AGN.PRA
| $107M | 0.97% |
104,200
| – | – |
|
|
WCG
35
DELISTED
Wellcare Health Plans, Inc.
WCG
| $105M | 0.95% |
1,346,200
+1,232,200
| +1,081% | +$96.4M |
|
|
ACHN
36
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $104M | 0.94% |
9,649,900
+4,427,400
| +85% | +$47.8M |
|
|
MNK
37
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $94.2M | 0.85% |
1,262,000
+89,000
| +8% | +$6.64M |
|
|
TSRO
38
DELISTED
TESARO, Inc.
TSRO
| $92.3M | 0.84% |
1,764,700
+29,500
| +2% | +$1.54M |
|
39
Community Health Systems
CYH
$395M
| $89.7M | 0.81% |
3,382,200
+662,000
| +24% | +$17.6M |
|
40
Vertex Pharmaceuticals
VRTX
$101B
| $84.7M | 0.77% |
673,000
+558,000
| +485% | +$70.2M |
|
|
IMGN
41
DELISTED
Immunogen Inc
IMGN
| $82.7M | 0.75% |
6,095,647
+2,501,647
| +70% | +$33.9M |
|
|
NUVA
42
DELISTED
NuVasive, Inc.
NUVA
| $80.5M | 0.73% |
1,487,000
| – | – |
|
|
AFFX
43
DELISTED
AFFYMETRIX INC
AFFX
| $75.8M | 0.69% |
7,511,000
| – | – |
|
44
Glaukos
GKOS
$5.37B
| $71.6M | 0.65% |
2,897,937
| – | – |
|
|
45
McKesson
MCK
$85.4B
| $68.9M | 0.62% |
349,372
-350,628
| -50% | -$69.2M |
|
|
PTLA
46
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $67M | 0.61% |
1,301,700
+317,000
| +32% | +$16.3M |
|
47
Insmed
INSM
$30.4B
| $63M | 0.57% |
3,469,900
+324,599
| +10% | +$5.89M |
|
|
LOXO
48
DELISTED
Loxo Oncology, Inc
LOXO
| $61.9M | 0.56% |
2,175,857
| – | – |
|
|
DMTX
49
DELISTED
Dimension Therapeutics, Inc
DMTX
| $60.9M | 0.55% |
+5,397,698
| New | +$60.9M |
|
|
BLUE
50
DELISTED
bluebird bio
BLUE
| $60.5M | 0.55% |
941,700
-247,200
| -21% | -$15.9M |
|